Study of BHV-1400 in IgA Nephropathy
Biohaven Therapeutics Ltd. · NCT07054684
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–65 · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Phase 1
- Target enrollment
- 20
- US sites recruiting
- 14
- Study start
- July 30, 2025
- Record last updated
- June 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to determine if BHV-1400 is a safe and tolerable treatment in participants with IgA Nephropathy (IgAN).
Being studied: BHV-1400
Conditions: IgA Nephropathy
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Key Inclusion Criteria
- Participants must have biopsy-confirmed IgA Nephropathy
Key Exclusion Criteria
- Any secondary IgAN
- Any cause of chronic kidney disease not diagnosed as IgAN or due to non-IgAN cause
Recruiting US locations
Site-001
Farmington, CT 06030
Site-003
Miami Lakes, FL 33016
Site-011
Miami Lakes, FL 33172
Site-013
Orlando, FL 32806
Site-005
Pembroke Pines, FL 33029
Site-008
Lawrenceville, GA 30046
Site-009
Hinsdale, IL 60521
Site-012
Indianapolis, IN 46268
Site-015
Shelby, MI 48316
Site-006
Chesterfield, MO 63017
Site-002
Dakota Dunes, SD 57049
Site-014
Houston, TX 77027
Site-004
Houston, TX 77099
Site-016
Salt Lake City, UT 84115
Study contacts (from the official record)
- Chief Medical Officer · 203-404-0410 · clinicaltrials@biohavenpharma.com
Similar studies in Connecticut
All phase 1 studies in Connecticut →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma
Pfizer
- Location
- New Haven, CT
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersEarly Phase 1Overnight stay mentioned
Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder
Yale University
- Location
- New Haven, CT
- Eligibility basics
- Ages 21–70
- RecruitingHealthy volunteersPhase 1
MK-0947 PN-002: An Open-label Study to Evaluate Brain α-synuclein Deposition Using Positron Emission Tomography (PET) and [¹⁸F]MK-0947 in Participants With Parkinson's Disease (PD)
XingImaging, LLC
- Location
- New Haven, CT
- Eligibility basics
- Ages 40–80
- RecruitingHealthy volunteersEarly Phase 1
A Study of the Pharmacokinetics, Biodistribution and Dosimetry of Granzyme-B Targeted [Cu-64]-Labeled PET Radiotracers in Adult Healthy Volunteers
Ratio Therapeutics, Inc.
- Location
- New Haven, CT
- Eligibility basics
- Ages 18–60